Board of Directors


Matt is an accomplished executive with a strong background in the rapid growth and early commercialization phases of technology companies. He currently serves as the President and CEO of Benson Hill Biosystems, an agricultural biotechnology company focused on crop yield improvement. Prior to co-founding Benson Hill Biosystems, he was the President of the Agricultural Biotechnology Division and Senior Vice President at Intrexon Corporation (NYSE:XON), a leading synthetic biology company. In addition to launching the company's agbiotech efforts, Matt worked with Intrexon for more than five years, serving in multiple executive roles and on its Board of Directors. Prior to formally joining Intrexon in early 2011, Matt was a Managing Director at Third Security, LLC, a globally recognized venture capital firm. During his time there, Matt focused on corporate development and worked closely with numerous private and public companies in the life science and technology sectors, as well as with NewVa Capital Partners, LP, an early-stage private equity fund focused on investments in southwestern Virginia. He also served on numerous boards of companies representing first-in-class and best-in-class technologies and led the firm's west coast operations from 2008 until 2011. Matt holds a Bachelor of Business Administration in Finance from Radford University, where he currently serves on its Board of Visitors, the College of Business and Economics Advisory Council, and on the Radford University Foundation Board of Directors as its President.


Tom has 28 years of leadership experience in the development and commercialization of agricultural biotechnology products. He is a recognized expert in the biosynthesis of plant/fungal isoprenoid products with 65 publications and patents. Prior to co-founding Edison Agrosciences, he was responsible for R&D portfolio development in the Agricultural Biotechnology Division of Intrexon Corporation, a major synthetic biology company. Before joining Intrexon, he founded Dorsan Biofuels, Inc. and participated in its sale to Novozymes. At Dorsan Biofuels, he helped raise seed funding and led a metabolic engineering project for the development of a fungal isoprenoid production platform. In the 11 years prior, Tom was at Syngenta and one of its legacy companies where he held various technical, regulatory, and business development roles. While Director of Disease Control Traits, he led the development of crop disease traits based on the genetic engineering of plant immunity to pathogen-produced toxins. Before joining Syngenta, as a Research Scientist at the USDA - Agricultural Research Service, National Center for Agricultural Utilization Research, Tom authored the first published report for a cloned terpene synthase gene from any source. He also cloned and characterized the key genetic and metabolic regulatory factors responsible for a fungal isoprenoid toxin pathway. He holds a B.S. in Biology/Chemistry from Central Michigan University and Ph.D. in Microbiology from Washington State University.

Page updated: 9/17/2017

Home / Contact Us
Content copyright 2018. Edison Agrosciences, Inc. All rights reserved.